| Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis S Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... Muscle & nerve 60 (1), 14-24, 2019 | 186 | 2019 |
| Neurostatus and EDSS calculation with cases S Şen Archives of Neuropsychiatry 55 (Suppl 1), S80, 2018 | 47 | 2018 |
| Eculizumab improves fatigue in refractory generalized myasthenia gravis H Andersen, R Mantegazza, JJ Wang, F O’Brien, K Patra, JF Howard Quality of life research 28, 2247-2254, 2019 | 46 | 2019 |
| SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study MP Sormani, I Schiavetti, D Landi, L Carmisciano, N De Rossi, C Cordioli, ... Multiple Sclerosis Journal 28 (7), 1034-1040, 2022 | 43 | 2022 |
| Safety of IV pulse methylprednisolone therapy during breastfeeding in patients with multiple sclerosis C Boz, M Terzi, S Zengin Karahan, S Sen, Y Sarac, M Emrah Mavis Multiple Sclerosis Journal 24 (9), 1205-1211, 2018 | 38 | 2018 |
| ‘Minimal symptom expression’in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab J Vissing, S Jacob, KP Fujita, F O’Brien, JF Howard Journal of neurology 267 (7), 1991-2001, 2020 | 34 | 2020 |
| Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial J Palace, DM Wingerchuk, K Fujihara, A Berthele, C Oreja-Guevara, ... Multiple sclerosis and related disorders 47, 102641, 2021 | 32 | 2021 |
| The use of non-steroidal anti-inflammatory drugs in neurological diseases M Terzi, G Altun, S Şen, A Kocaman, AA Kaplan, KK Yurt, S Kaplan Journal of chemical neuroanatomy 87, 12-24, 2018 | 31 | 2018 |
| Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: multi-center, controlled trial S Ozakbas, R Turkoglu, Y Tamam, M Terzi, O Taskapilioglu, C Yucesan, ... Multiple sclerosis and related disorders 22, 70-76, 2018 | 30 | 2018 |
| The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals? S Sen, R Karabudak, I Schiavetti, S Demir, S Ozakbas, M Tutuncu, ... Multiple sclerosis and related disorders 52, 102968, 2021 | 26 | 2021 |
| Consistent improvement with eculizumab across muscle groups in myasthenia gravis R Mantegazza, FL O'Brien, M Yountz, JF Howard Jr, REGAIN Study Group, ... Annals of clinical and translational neurology 7 (8), 1327-1339, 2020 | 20 | 2020 |
| Teriflunomide and time to clinical multiple sclerosis in patients with radiologically isolated syndrome: the TERIS randomized clinical trial C Lebrun-Frénay, A Siva, MP Sormani, C Landes-Chateau, L Mondot, ... JAMA neurology 80 (10), 1080-1088, 2023 | 18 | 2023 |
| Methylprednisolone concentrations in breast milk and serum of patients with multiple sclerosis treated with IV pulse methylprednisolone SZ Karahan, C Boz, M Terzi, G Aktoz, S Sen, B Ozbudun, A Caglar, ... Clinical Neurology and Neurosurgery 197, 106118, 2020 | 17 | 2020 |
| Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study ZA Siddiqi, RJ Nowak, T Mozaffar, F O'Brien, M Yountz, F Patti, ... Muscle & nerve 64 (6), 662-669, 2021 | 12 | 2021 |
| Screening of dysphagia by DYMUS (Dysphagia in multiple sclerosis) and SWALQoL (Swallowing quality of life) surveys in patients with multiple sclerosis E Tahir, E Kavaz, Ö Kemal, S Şen, M Terzi Multiple Sclerosis and Related Disorders 45, 102397, 2020 | 9 | 2020 |
| The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real‐world study from Turkey C Uzunköprü, M Tütüncü, T Gündüz, H Gümüş, S Şen, S Demir, BP Çınar, ... International Journal of Clinical Practice 75 (7), e14158, 2021 | 7 | 2021 |
| The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course? S Sen, A Tuncer, S Ozakbas, C Uzunkopru, C Baba, S Demir, ... Multiple Sclerosis and Related Disorders 58, 103399, 2022 | 6 | 2022 |
| Is RLS a harbinger and consequence of MS?: Striking results of the ‘RELOMS-T’study S Sevim, M Demirkıran, M Terzi, N Yüceyar, B Taşdelen, E İdiman, ... Multiple sclerosis and related disorders 42, 102055, 2020 | 6 | 2020 |
| Chromosome number and abnormalities in Bougainvillea SN Sen, NK Sen Bull Bot. Sur. Bengal 8, 140-142, 1954 | 5 | 1954 |
| Volumetric changes in hypothalamic subunits in patients with relapsing remitting multiple sclerosis B Genç, S Şen, K Aslan, L İncesu Neuroradiology 65 (5), 899-905, 2023 | 4 | 2023 |
Aksel SivaIstanbul University Cerrahpasa School of MedicineVerified email at iuc.edu.tr
